[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/main/docs/Risk/index.md) >> Individual ID:PBN__Risk_1801 

# __Delayed drug development__

## Property: has_RiskType

* [technological](https://github.com/mm80843/T3.5/blob/main/docs/RiskType/PBN__RiskType_5.md)

## People affected by this risk

* [researchers](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_2.md)
* [pharmaceutical companies](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_124.md)

## Name of the risk

Limited treatment options and prolonged pandemic

## Property: has_RiskISO_Purpose

* [Economy and sustainable production and consumption](https://github.com/mm80843/T3.5/blob/main/docs/RiskISO/PBN__RiskISO_Impact_10.md)

## Closest similar item

* [Slow drug development](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_466.md)
* [Development of drugs](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_431.md)
* [Delayed treatment](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3273.md)
* [Lack of effective drugs](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2724.md)
* [Lack of effective pharmaceutical response](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1602.md)
* [Lack of drug therapy options](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1146.md)
* [Slowed development, lack of progress](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3256.md)
* [Lack of accessibility of pharmaceutical interventions in developing countries](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_727.md)
* [Lack of access to pharmaceutical interventions](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1158.md)
* [Insufficient non-pharmaceutical interventions](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1603.md)

## Description of the risk

Slow process of drug testing and discovery

## Technologies linked to the risk

* [none](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_35.md)

## Property: has_RiskHealth

* [physical](https://github.com/mm80843/T3.5/blob/main/docs/RiskHealth/PBN__RiskHealth_0.md)

## Mitigations of this risk

* [Utilize AI methods for faster drug testing and discovery](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2379.md)

## Articles mentionning the risk

* [Exploring the Potential of Artificial Intelligence and Machine Learning to Combat COVID-19 and Existing Opportunities for LMIC: A Scoping Review](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_131.md)

## Property: has_RiskISO_Impact

* [Biodiversity and ecosystem services](https://github.com/mm80843/T3.5/blob/main/docs/RiskISO/PBN__RiskISO_Purpose_4.md)

## Property: has_RiskGBN

* [No](https://github.com/mm80843/T3.5/blob/main/docs/RiskGBN/PBN__RiskGBN_0.md)

## Stakeholders who can mitigate this risk

* [researchers](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_2.md)
* [drug developers](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_1200.md)

